Calendar Vanda Pharmaceuticals Inc.

Equities

VNDA

US9216591084

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 21:00:00 18/02/2026 GMT			5-day change	1st Jan Change
6.030 ^USD	-2.74%		-18.84%	-31.63%

02-12	Vanda Pharmaceuticals Inc files for mixed shelf offering of up to $200 million - SEC filing	RE
02-12	Vanda Pharmaceuticals Inc., Q4 2025 Earnings Call, Feb 11, 2026

Chart calendar Vanda Pharmaceuticals Inc.

bf2cf4.BdOrG6ILxCBouVLOkv2BQSpa9H4CBtZQnwwJA7P6c_s.NObNT5RAhhA_7Qek-rq5C2k-uxdKY-895kpEc4WQPr5HhuVxjzujQiDdGw~2ffe898de3074d8bfe2a5ad277151dbd

Upcoming events on Vanda Pharmaceuticals Inc.

05/05/2026	Q1 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
04/08/2026	Q2 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
03/11/2026	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
09/02/2027	Q4 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format

Past events on Vanda Pharmaceuticals Inc.

11/02/2026	Q4 2025 Earnings Call
11/02/2026	Q4 2025 Earnings Release
15/01/2026	J.P. Morgan Healthcare Conference
12/11/2025	Stifel Healthcare Conference
29/10/2025	Q3 2025 Earnings Call
29/10/2025	Q3 2025 Earnings Release
09/09/2025	H.C. Wainwright Global Investment Conference
04/09/2025	Wells Fargo Healthcare Conference
03/09/2025	Cantor Global Healthcare Conference
31/07/2025	Q2 2025 Earnings Call
31/07/2025	Q2 2025 Earnings Release
05/06/2025	Annual General Meeting
26/05/2025	American Society of Clinical Psychopharmacology Meeting - Poster Number: T19
20/05/2025	Mizuho Neuro & Ophthalmology Summit
07/05/2025	Q1 2025 Earnings Call
07/05/2025	Q1 2025 Earnings Release
08/04/2025	American Academy of Neurology Meeting - Poster Number: 11-017
13/02/2025	Q4 2024 Earnings Call
13/02/2025	Q4 2024 Earnings Release
21/11/2024	Jefferies London Healthcare Conference

Annual results

Fiscal Period	December	2023	2024	2025	2026	2027	2028
Net sales Million USD	Released Forecast Spread	193 184 4.47%	199 199 -0.34%	216 218 -0.95%	254	339	410
EBITDA	Released Forecast Spread	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00	0,00	0,00
EBIT Million USD	Released Forecast Spread	-14,0 -18,4 24.17%	-40,7 -38,4 -5.99%	-151 -143 -5.64%	-154	-75,1	-29,7
Earnings before Tax (EBT) Million USD	Released Forecast Spread	6,34 2,60 143.81%	-22,9 -21,8 -5.38%	-139 -127 -8.74%	-137	-60,3	-23,7
Net income Million USD	Released Forecast Spread	2,51 -0,50 601.8%	-18,9 -18,7 -0.96%	-220 -158 -39.8%	-132	-58,8	-23,9
EPS USD	Released Forecast Spread	0,04 -0,01 500%	-0,33 -0,32 -3.13%	-3,74 -2,67 -39.94%	-2,23	-0,85	-0,30
Announcement Date		07/02/24	13/02/25	11/02/26	-

Quarterly results

Fiscal Period	December	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4
Net sales Million USD	Released Forecast Spread	50,5 47,9 5.46%	47,7 49,2 -3.06%	53,2 52,3 1.79%	50,0 45,1 10.87%	52,6 54,8 -3.97%	56,3 58,7 -4.21%	57,2 59,3 -3.47%	53,5	60,5	66,7	73,3
EBIT Million USD	Released Forecast Spread	-10,1 -17,0 40.36%	-11,0 -14,8 25.44%	-10,3 -10,4 0.94%	-41,0 -42,0 2.35%	-38,5 -25,3 -52.36%	-31,3 -34,6 9.58%	-40,4 -32,2 -25.19%	-45,5	-37,8	-37,7	-33,9
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-5,52 -12,4 55.41%	-6,24 -10,2 38.83%	-6,50 -6,94 6.37%	-37,4 -35,3 -5.82%	-34,9 -21,5 -62.27%	-28,4 -28,0 -1.31%	-38,0 -26,7 -42.12%	-40,7	-34,0	-33,0	-29,1
Net income Million USD	Released Forecast Spread	-4,52 -12,4 63.48%	-5,32 -9,54 44.21%	-4,91 -6,33 22.43%	-29,5 -35,0 15.84%	-27,2 -21,1 -28.74%	-22,6 -27,0 16.42%	-141 -78,2 -80.46%	-40,1	-33,5	-30,8	-27,2
EPS USD	Released Forecast Spread	-0,08 -0,21 61.9%	-0,09 -0,16 44.9%	-0,08 -0,11 27.27%	-0,50 -0,60 16.2%	-0,46 -0,36 -28.97%	-0,38 -0,45 16.18%	-2,39 -1,33 -80.38%	-0,68	-0,57	-0,52	-0,46
Announcement Date		31/07/24	06/11/24	13/02/25	07/05/25	31/07/25	29/10/25	11/02/26	-	-	-	-

Upcoming sector events for Vanda Pharmaceuticals Inc.

Today	ZEALAND PHARMA A/S	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
Today	INSMED INCORPORATED	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
Today	MADRIGAL PHARMACEUTICALS, INC.	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
Today	TRAVERE THERAPEUTICS, INC.	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
22/02/2026	LUMOSA THERAPEUTICS CO., LTD.	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
23/02/2026	VAXCYTE, INC.	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
24/02/2026	ARVINAS, INC.	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
24/02/2026	CYTOKINETICS, INCORPORATED	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
24/02/2026	GERON CORPORATION	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
24/02/2026	SOLENO THERAPEUTICS, INC.	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format

More events

Past sector events for Vanda Pharmaceuticals Inc.

Today	EDGEWISE THERAPEUTICS, INC.	Q4 2025 Earnings Release (Projected)
Today	DYNAVAX TECHNOLOGIES CORPORATION	Q4 2025 Earnings Release (Projected)
Today	ARDELYX, INC.	Q4 2025 Earnings Release
17/02/2026	SAGE THERAPEUTICS, INC.	Q4 2025 Earnings Release (Projected)
17/02/2026	GENMAB A/S	Q4 2025 Earnings Release
17/02/2026	COGENT BIOSCIENCES, INC.	Q4 2025 Earnings Release
17/02/2026	INVENTIVA	Q4 2025 Sales and Revenue Release
15/02/2026	PEPTIDREAM INC.	Q4 2025 Earnings Release
12/02/2026	BIOCON LIMITED	Q3 2026 Earnings Release
12/02/2026	AGIOS PHARMACEUTICALS, INC.	Q4 2025 Earnings Release